dr. ferris on impact of fda approval of pembrolizumab in patients with head and neck cancer
Published 7 years ago • 230 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:17
dr. ferris on fda approval of nivolumab in patients with head and neck cancer
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
1:36
dr. ferris on potential of nivolumab in head and neck cancer
-
1:15
dr. ferris on significance of checkmate-141 trial for head and neck cancer
-
2:25
dr. ferris on checkmate-141 trial in head and neck cancer
-
0:57
dr. joshua m. bauml on the impact of pembrolizumab in head and neck cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
1:04
dr. monk on the fda approval of pembrolizumab in cervical cancer
-
1:27
dr. grothey on fda approval of pembrolizumab in msi-high crc
-
1:23
dr. burtness on the benefit of pembrolizumab in head and neck cancer
-
0:40
dr. joshua m. bauml on pembrolizumab versus chemo in head and neck cancers
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) for the adjuvant treatment...
-
1:18
dr. joel neal on impact of pd-l1 tests on pembrolizumab, nivolumab efficacy in frontline nsclc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
3:01
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) in combination with trastu...
-
0:58
dr. machiels on pembrolizumab in head and neck cancer
-
0:40
dr. vokes on selecting nivolumab or pembrolizumab for head and neck cancer treatment
-
2:13
dr. malhotra on pembrolizumab during concurrent chemoradiation in nsclc